Tada wrote: "If my recollection is correct the highest recruiting numbers came in Apr, May, & Jun of 2016. As those patients pass the 120 week point there will be no more expense of carrying them."

First patient dosed November 11, 2015. First enrollment updates I recall was around September 12, 2016 (~600 patients total) and then another 200 patients reportred by the next update December 15, 2016 (~800 patients total). Therefore, if the trial ends by end of 2018, then only ~800 of ~2400 patients will have reached the 120 week point. While I acknowledge costs will go down as these patients complete their dosing/follow up, I don't agree with your statement that highest recruiting numbers came in Apr/May/Jun 2016.

BDAZ